{"id":373,"date":"2026-11-06T17:04:19","date_gmt":"2026-11-06T11:34:19","guid":{"rendered":"https:\/\/incepbio.com\/blog\/?p=373"},"modified":"2026-11-06T17:10:40","modified_gmt":"2026-11-06T11:40:40","slug":"process-validation-in-pharma","status":"publish","type":"post","link":"https:\/\/incepbio.com\/blog\/process-validation-in-pharma\/","title":{"rendered":"Process Validation in Pharma: 3 Stages of the FDA Lifecycle Approach"},"content":{"rendered":"\t\t
\n\t\t\t\t
\n \t\t\t

Process validation shows that a manufacturing process consistently delivers product that meets its quality requirements. The FDA's 2011 guidance, Process Validation: General Principles and Practices<\/em>, treats it as a lifecycle activity with three stages: Process Design, Process Qualification, and Continued Process Verification (CPV). This article explains each stage, the records behind it, and the problems teams meet in practice.<\/p>\n\t\t\n<\/div>\n

\n \t\t\t

What Is Process Validation in Pharmaceutical Manufacturing?<\/strong><\/h2>\n\t\t\n<\/div>\n
\n \t\t\t

Process validation is the collection and evaluation of data from process design through commercial production. It provides scientific evidence that a manufacturing process can consistently deliver products that meet their predefined quality requirements.<\/p>\n\t\t\n<\/div>\n

\n \t\t\t

It is important to distinguish qualification from validation. Qualification demonstrates that facilities, utilities, and equipment are suitable for their intended use. Process validation goes further by providing documented evidence that the manufacturing process, operating with qualified systems and established controls, can consistently produce products that meet predefined quality requirements. 
<\/p>\n\t\t\n<\/div>\n

\n \t\t\t

Why Is Process Validation Important in Pharma?<\/strong><\/h2>\n\t\t\n<\/div>\n
\n \t\t\t

Finished-product testing alone cannot guarantee consistent product quality. Pharmaceutical manufacturers must establish controlled manufacturing procedures and appropriate in-process controls to reduce variability and prevent quality failures.<\/p>\n\t\t\n<\/div>\n

\n \t\t\t

In the United States, CGMP requirements for finished drug products include 21 CFR 211.100, which requires written production and process control procedures, and 21 CFR 211.110, which addresses in-process sampling and testing. These are binding regulations. The FDA's 2011 Process Validation guidance, on the other hand, provides nonbinding recommendations for implementing a science- and risk-based lifecycle approach.<\/p>\n\t\t\n<\/div>\n

\n \t\t\t

Understanding the FDA's Three-Stage Lifecycle Approach<\/strong><\/h2>\n\t\t\n<\/div>\n
\n \t\t\t

The stages run in sequence, but later data feeds back into earlier decisions.<\/p>\n\t\t\n<\/div>\n

\n \t\t\t

Stage 1 \u2013 Process Design<\/strong><\/h3>\n\t\t\n<\/div>\n
\n \t\t\t

Process Design defines the commercial manufacturing process using knowledge from development and scale-up. Teams set the process steps, identify variables, and build a control strategy to carry into manufacturing<\/p>\n\t\t\n<\/div>\n

\n \t\t\t

Understanding Process Variables and Critical Quality Attributes<\/strong><\/h4>\n\t\t\n<\/div>\n
\n \t\t\t

A critical quality attribute (CQA) is a physical, chemical, biological, or microbiological property that must stay within limits to ensure product quality. A Critical Process Parameter (CPP) is a process variable whose variation affects a CQA, so it must be monitored or controlled.<\/p>\n\t\t\n<\/div>\n

\n \t\t\t

Consider a tablet manufacturing line as an illustrative example. Content uniformity and dissolution may be identified as Critical Quality Attributes (CQAs). Blend time and compression force may be potential Critical Process Parameters (CPPs), depending on process understanding and evidence of their impact on product quality.<\/p>\n\t\t\n<\/div>\n

\n \t\t\t

Risk assessments and design of experiments can help teams understand these relationships and determine which process variables require monitoring or control.Type your paragraph here<\/p>\n\t\t\n<\/div>\n

\n \t\t\t

Stage 2 \u2013 Process Qualification<\/strong><\/h3>\n\t\t\n<\/div>\n
\n \t\t\t

Process Qualification evaluates whether the process design is capable of reproducible commercial manufacturing. According to the FDA lifecycle approach, Stage 2 includes two elements:<\/p>\n\t\t\n<\/div>\n

\n\t\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t\t\t\t\t
    \n
  1. \n Facility design:<\/strong> Along with qualification of equipment and utilities.\n <\/li>\n
  2. \n Process Performance Qualification (PPQ):<\/strong> Demonstrates that the commercial manufacturing process performs as expected.\n <\/li>\n<\/ol>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t
    \n \t\t\t

    Facility, utility, and equipment qualification establish the foundation for PPQ. However, qualifying these systems alone does not demonstrate that the manufacturing process is capable of consistently producing quality products.<\/p>\n\t\t\n<\/div>\n

    \n \t\t\t

    Qualification of Facilities, Utilities and Equipment<\/strong><\/h4>\n\t\t\n<\/div>\n
    \n \t\t\t

    Before PPQ begins, the relevant facilities, utilities, and equipment should be appropriately qualified. This may include HVAC systems, compressed gases, and manufacturing equipment, depending on the process.<\/p>\n\t\t\n<\/div>\n

    \n \t\t\t

    Qualification activities provide documented evidence that these systems are installed and operate as intended. Activities may include Installation Qualification (IQ), Operational Qualification (OQ), and Performance Qualification (PQ), as applicable.<\/p>\n\t\t\n<\/div>\n

    \n \t\t\t

    These activities establish the foundation for PPQ by confirming that the systems supporting manufacturing are suitable for their intended use.<\/p>\n\t\t\n<\/div>\n

    \n\t\t\t\t\t
    \n\t\t\t\t
    \n\t\t\t\t\t\t\t\t\tOur guide to pharmaceutical equipment qualification<\/a> covers IQ, OQ, and PQ in detail.\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t
    \n \t\t\t

    Process Performance Qualification (PPQ)<\/strong><\/h4>\n\t\t\n<\/div>\n
    \n \t\t\t

    Process Performance Qualification (PPQ) is the second element of Stage 2. It combines qualified facilities, utilities, and equipment with trained personnel, approved procedures, and the commercial manufacturing process to demonstrate that the process performs as expected.<\/p>\n\t\t\n<\/div>\n

    \n \t\t\t

    A typical PPQ activity involves:<\/p>\n\t\t\n<\/div>\n

    \n\t\t\t\t\t
    \n\t\t\t\t
    \n\t\t\t\t\t\t\t\t\t
    \n\n
    \n

    \n Prepare the PPQ protocol\n <\/h4>\n

    \n Define manufacturing conditions, operating parameters, sampling plans, testing requirements, and acceptance criteria.\n <\/p>\n <\/div>\n\n

    \n

    \n Execute commercial-scale batches\n <\/h4>\n

    \n Manufacture batches under normal operating conditions using trained personnel and approved procedures.\n <\/p>\n <\/div>\n\n

    \n

    \n Collect and evaluate data\n <\/h4>\n

    \n Review in-process results, finished-product testing, deviations, and process performance against predefined criteria.\n <\/p>\n <\/div>\n\n

    \n

    \n Prepare the PPQ report\n <\/h4>\n

    \n Summarise the results, assess deviations and document whether the process demonstrates reproducible performance.\n <\/p>\n <\/div>\n\n<\/div>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t

    \n \t\t\t

    The number of PPQ batches should be justified using process understanding, manufacturing complexity, variability, and the evidence needed to demonstrate reproducible performance. The FDA guidance does not prescribe a universal number of batches.<\/p>\n\t\t\n<\/div>\n

    \n \t\t\t

    Successful completion of Stage 2 is necessary before commercial distribution under the FDA lifecycle approach. The decision should be supported by documented commercial-scale data and quality unit review.<\/p>\n\t\t\n<\/div>\n

    \n\t\t\t\t\t
    \n\t\t\t\t
    \n\t\t\t\t\t\t\t\t\t
    \n\n

    \n Getting Ready for Process Qualification?\n <\/h3>\n\n

    \n Make sure your facilities, utilities, and equipment are ready. Explore how IncepBio can support your CQV requirements.\n <\/p>\n\n \n Explore CQV Services<\/span>\n <\/a>\n\n<\/div>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t

    \n \t\t\t

    Stage 3 \u2013 Continued Process Verification<\/strong><\/h3>\n\t\t\n<\/div>\n
    \n \t\t\t

    CPV is an ongoing program that collects and analyses product and process data to confirm the process remains in a state of control.<\/p>\n\t\t\n<\/div>\n

    \n \t\t\t

    Monitoring Process Performance and Product Quality<\/strong><\/h4>\n\t\t\n<\/div>\n
    \n \t\t\t

    During Continued Process Verification, teams regularly collect and analyse relevant process and product data to confirm that the manufacturing process remains in a state of control.<\/p>\n\t\t\n<\/div>\n

    \n \t\t\t

    Monitoring may include Critical Process Parameters (CPPs), Critical Quality Attributes (CQAs), in-process test results, production yields, deviations and other relevant quality indicators.<\/p>\n\t\t\n<\/div>\n

    \n \t\t\t

    The CPV programme should also define how frequently data will be reviewed, how trends will be assessed and who is responsible for investigating unexpected variations.<\/p>\n\t\t\n<\/div>\n

    \n \t\t\t

    For example, if the fill volume on a vial production line gradually moves towards its acceptance limit, trend analysis can help identify the shift before it results in a batch failure. Teams can investigate the cause, implement corrective actions, and use change control to assess whether additional qualification or validation activities are needed.<\/p>\n\t\t\n<\/div>\n

    \n \t\t\t

    CPV is therefore an ongoing activity throughout routine commercial manufacturing.
    <\/p>\n\t\t\n<\/div>\n

    \n \t\t\t

    Key Documents Required for Pharmaceutical Process Validation<\/strong><\/h2>\n\t\t\n<\/div>\n
    \n \t\t\t

    Process validation requires documented evidence to support decisions at every stage of the lifecycle. Although the FDA guidance does not prescribe a universal list of document titles, manufacturers typically maintain records that demonstrate process understanding, qualification, PPQ results, and continued monitoring.<\/p>\n\t\t\n<\/div>\n

    \n \t\t\t

    Common documents include:<\/p>\n\t\t\n<\/div>\n

    \n\t\t\t\t\t
    \n\t\t\t\t
    \n\t\t\t\t\t\t\t\t\t\n
    \n